ask="44.75"
ask_size="300"
average_daily_volume="1579740"
bid="42.00"
bid_size="500"
book_value="11.83"
change="+1.27"
change_from_200_day_moving_average="-12.32"
change_from_50_day_moving_average="0.98"
change_from_52_week_high="-44.61"
change_From_52_week_low="12.12"
change_in_percent="+3.01%"
close="43.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="43.75"
high_52_weeks="88.11"
last_trade_date="1/9/2017"
last_trade_price="43.50"
last_trade_size="310902"
last_trade_time="4:00pm"
low="41.65"
low_52_weeks="31.38"
market_capitalization="3.73B"
moving_average_200_day="55.82"
moving_average_50_day="42.52"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="61.36"
open="42.89"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="-22.07%"
percent_change_from_50_day_moving_average="+2.30%"
percent_change_from_52_week_high="-50.63%"
percent_change_from_52_week_low="+38.62%"
previous_close="42.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.57"
price_per_sales="97.27"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="1849318"
weeks_range_52="31.38 - 88.11"
